Abrdn Life Sciences Investors (HQL) To Go Ex-Dividend on November 21st

Abrdn Life Sciences Investors (NYSE:HQL) declared a quarterly dividend on Wednesday, November 13th,Wall Street Journal reports. Stockholders of record on Thursday, November 21st will be paid a dividend of 0.50 per share on Friday, January 10th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 13.87%. The ex-dividend date is Thursday, November 21st. This is a boost from Abrdn Life Sciences Investors’s previous quarterly dividend of $0.49.

Abrdn Life Sciences Investors Stock Performance

HQL opened at $14.42 on Friday. The business has a 50-day moving average of $15.03 and a two-hundred day moving average of $14.64. Abrdn Life Sciences Investors has a 12 month low of $11.62 and a 12 month high of $15.90.

About Abrdn Life Sciences Investors

Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries.